Price$17.55-0.69 (-3.78%)
2026-03-052026-06-08
News · 26 weeks85+100%
2025-12-142026-06-07
Mix3190d
- Insider18(58%)
- SEC Filings6(19%)
- Other4(13%)
- Earnings2(6%)
- Dividends1(3%)
Latest news
25 items- SECSEC Form SD filed by Kenvue Inc.SD - Kenvue Inc. (0001944048) (Filer)
- INSIDERSEC Form 4 filed by Director Smith Jeffrey C4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Hofstetter Sarah4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Holden Betsy D4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Merlo Larry J4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Sneed Michael E4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Prabhu Vasant M4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERGroup President LATAM Curado Gomes De Lemos Leonardo converted options into 24,248 shares and covered exercise/tax liability with 7,141 shares (SEC Form 4)4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Healey Melanie4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Pawlus Kathleen M4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Mann Erica L4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Allison Richard E Jr4 - Kenvue Inc. (0001944048) (Issuer)
- INSIDERSEC Form 4 filed by Director Godbole Seemantini4 - Kenvue Inc. (0001944048) (Issuer)
- SECKenvue Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Kenvue Inc. (0001944048) (Filer)
- INSIDERGeneral Counsel Orlando Matthew sold $679,691 worth of shares (38,491 units at $17.66), closing all direct ownership in the company (SEC Form 4)4 - Kenvue Inc. (0001944048) (Issuer)
- SECSEC Form 10-Q filed by Kenvue Inc.10-Q - Kenvue Inc. (0001944048) (Filer)
- SECKenvue Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Kenvue Inc. (0001944048) (Filer)
- PRKenvue Reports First Quarter 2026 ResultsNet Sales Increased 4.5%; Organic Sales1 Increased 0.7% Diluted EPS Increased 47% to $0.25; Adjusted Diluted EPS1 Increased 33% to $0.32 Kenvue Inc. (NYSE:KVUE) today announced financial results for the fiscal first quarter ended March 29, 2026. "Our year is off to an encouraging start, as our continued efforts to strengthen the business and sharpen execution resulted in delivering net and organic sales growth for the second consecutive quarter, along with meaningful year-over-year improvement in gross margin, operating margin, and EPS," said Kirk Perry, Chief Executive Officer. "We remain confident in our ability to navigate ongoing macro uncertainty, as we accelerate our organiz
- SECSEC Form SCHEDULE 13G filed by Kenvue Inc.SCHEDULE 13G - Kenvue Inc. (0001944048) (Subject)
- PRKenvue Declares Quarterly Cash DividendKenvue Inc. (NYSE:KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is payable on May 27, 2026, to shareholders of record as of the close of business on May 13, 2026. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in con
- PRKenvue to Announce First Quarter 2026 Results on May 7, 2026Kenvue Inc. (NYSE:KVUE) will announce its first quarter 2026 financial results before the market opens on May 7, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its financial results. The press release will be available on the company's website at investors.kenvue.com. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the
- SECKenvue Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Kenvue Inc. (0001944048) (Filer)
- PRKimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key LeadershipDALLAS, April 15, 2026 /PRNewswire/ -- Kimberly‑Clark Corporation (NASDAQ: KMB) today announced the organizational structure and key leadership that will become effective upon completion of its pending acquisition of Kenvue Inc. (NYSE:KVUE). The organizational structure, roles, and responsibilities reflect the fast-and-lean, balanced matrix approach that has built strong operating momentum at Kimberly-Clark since implementing its Powering Care strategy two years ago. "We are excited to name the leadership team that will guide us forward to create a new kind of health and wellness company poised to raise the standard of care for billions of consumers across every stage of life," said Mike Hsu
- SECSEC Form DEFA14A filed by Kenvue Inc.DEFA14A - Kenvue Inc. (0001944048) (Filer)
- SECSEC Form DEF 14A filed by Kenvue Inc.DEF 14A - Kenvue Inc. (0001944048) (Filer)
KVUE FAQ
6 questionsWhere does KVUE stock trade?
Kenvue Inc. (KVUE) is listed on NYSE.What sector and industry is KVUE in?
Kenvue Inc. operates in the Consumer Discretionary sector, Specialty Chemicals industry.When did Kenvue Inc. go public?
Kenvue Inc. (KVUE) completed its IPO in 2023.What are analysts saying about KVUE?
Kenvue Inc. has had 8 recent analyst actions on file. The most recent action was from Jefferies: Hold with a $1800.00 price target on 2026-01-30. Recent price targets range from $1500.00 to $2700.00.What companies are similar to KVUE?
Notable peers in the same industry include CSL (Carlisle Companies Incorporated), CLX (Clorox Company), UNVR (Univar Solutions Inc.), DSEY (Diversey Holdings Ltd.), HWKN (Hawkins Inc.). Compare KVUE side-by-side with any of them on Quantisnow.How can I track KVUE on Quantisnow?
Quantisnow aggregates Kenvue Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KVUE to receive live email and push alerts on every new disclosure.